Prestige Consumer Healthcare Inc. Reports Fiscal 2019 Fourth Quarter and Full-Year Results

Go back to Prestige Consumer Healthcare Inc. Reports Fiscal 2019 Fourth Quarter and Full-Year Results

Prestige Brands (PBH) Tops Q4 EPS by 1c, Revenues Beat; Affirms FY20 EPS Mid-Point Guidance Below Consensus, Provides FY20 Revenue Outlook, Board Approves New $50M Buyback

May 9, 2019 6:21 AM EDT

Prestige Brands (NYSE: PBH) reported Q4 EPS of $0.72, $0.01 better than the analyst estimate of $0.71. Revenue for the quarter came in at $241 million versus the consensus estimate of $237.22 million.

Revenue was $241.0 Million in Q4 and $975.8 Million in Full-Year Fiscal 2019Organic Revenue Grew 3.2% in Q4 and 0.1% in Fiscal 2019Reduced Debt by $200 Million and Repurchased $50 Million of Shares in Fiscal 2019Board of Directors Authorizes New $50 Million Share Repurchase Program

We again executed against our three-pillar strategy in fiscal 2019, delivering solid earnings, cash flow and market share gains. These performance... More